Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Bladder preservation with systemic therapy alone: are we losing sight of survival?
Journal: BJU international
Published: September 01, 2026
Beyond the NMIBC-MIBC Dichotomy: Integrating Molecular Biomarkers into Bladder Cancer Risk Stratification.
Journal: The Journal of urology
Published: August 11, 2026
Outcomes of maintenance BCG versus gemcitabine/docetaxel following BCG induction in NMIBC.
Journal: BJU international
Published: July 04, 2026
Metachronous Contralateral Recurrence in Upper Tract Urothelial Carcinoma: A Multi-Institutional Competing-Risks Analysis From the ROBUUST 3.0 Registry.
Journal: Urology practice
Published: June 22, 2026
Artificial intelligence and predictive tools in non-muscle invasive bladder cancer: a narrative review of current insights and advances.
Journal: Translational andrology and urology
Published: April 10, 2026
New CPT codes for prostate biopsy improve alignment of reimbursement with evidence-based practice.
Journal: Urologic oncology
Published: April 03, 2026
BCG-unresponsive NMIBC: An Obsolete Definition in a Multimodal and Evolving Therapeutic Landscape.
Journal: European urology
Published: February 04, 2026
Prognostic Value of Perioperative Circulating Tumor DNA in Pure Urothelial Carcinoma and Histological Subtypes of Bladder Cancer.
Journal: European urology focus
Published: January 28, 2026
Prognostic Utility of ctDNA for Trimodality Therapy Outcomes in Muscle Invasive Bladder Cancer.
Journal: Clinical genitourinary cancer
Published: December 17, 2025
Durable responses to immune checkpoint inhibitor-based regimens for metastatic clear cell renal cell carcinoma stratified by IMDC risk groups: A pooled analysis of four randomized phase 3 trials.
Journal: Kidney cancer (Clifton, Va.)
Published: July 01, 2025
Last Updated: 09/26/2026